看來載入頁面時發生了錯誤.
我們的團隊已收到通知,但若此問題持續,請透過電郵支援widget工具聯絡我們。
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBIT Multiple | 8.5x - 9.4x | 9.0x |
Selected Fwd EBIT Multiple | 7.8x - 8.6x | 8.2x |
Fair Value | €11.29 - €12.45 | €11.87 |
Upside | 4.9% - 15.7% | 10.3% |
Benchmarks | Ticker | Full Ticker |
Paul Hartmann AG | PHH2 | DB:PHH2 |
Eckert & Ziegler SE | EUZ | DB:EUZ |
Medacta Group SA | MOVE | SWX:MOVE |
Svas Biosana S.p.A. | SVS | BIT:SVS |
Nyxoah SA | NYXH | ENXTBR:NYXH |
Ion Beam Applications SA | IOB | DB:IOB |
- | - | - |
Select LTM EBIT Multiple | |||||||
Benchmark Companies | |||||||
PHH2 | EUZ | MOVE | SVS | NYXH | IOB | ||
DB:PHH2 | DB:EUZ | SWX:MOVE | BIT:SVS | ENXTBR:NYXH | DB:IOB | ||
Historical EBIT Growth | |||||||
5Y CAGR | 0.9% | 14.5% | 18.3% | 5.1% | NM- | NM- | |
3Y CAGR | -8.6% | 25.9% | 11.5% | 19.3% | NM- | 27.2% | |
Latest Twelve Months | 22.9% | 25.6% | 37.9% | 18.4% | -55.8% | 50.3% | |
Historical EBIT Profit Margin | |||||||
5 Year Average Margin | 4.1% | 20.0% | 16.6% | 7.1% | -4002.8% | 5.4% | |
Prior Fiscal Year | 0.9% | 19.0% | 15.0% | 7.0% | -1037.3% | 1.6% | |
Latest Fiscal Year | 4.5% | 22.5% | 15.7% | 8.0% | -1300.8% | 5.6% | |
Latest Twelve Months | 3.3% | 23.2% | 16.7% | 8.2% | -1495.6% | 6.5% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 0.50x | 3.36x | 5.34x | 0.67x | 36.05x | 0.53x | |
EV / LTM EBITDA | 8.3x | 12.3x | 21.4x | 5.7x | -2.4x | 7.4x | |
EV / LTM EBIT | 15.0x | 14.4x | 32.0x | 8.2x | -2.4x | 8.2x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBIT | -2.4x | 14.4x | 32.0x | ||||
Historical EV / LTM EBIT | -86.4x | 13.1x | 25.0x | ||||
Selected EV / LTM EBIT | 8.5x | 9.0x | 9.4x | ||||
(x) LTM EBIT | 38 | 38 | 38 | ||||
(=) Implied Enterprise Value | 324 | 341 | 358 | ||||
(-) Non-shareholder Claims * | 8 | 8 | 8 | ||||
(=) Equity Value | 332 | 349 | 366 | ||||
(/) Shares Outstanding | 29.3 | 29.3 | 29.3 | ||||
Implied Value Range | 11.34 | 11.92 | 12.51 | ||||
FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | |||
Implied Value Range (Trading Cur) | 11.34 | 11.92 | 12.51 | 10.76 | |||
Upside / (Downside) | 5.4% | 10.8% | 16.2% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | PHH2 | EUZ | MOVE | SVS | NYXH | IOB | |
Enterprise Value | 1,222 | 999 | 3,443 | 91 | 190 | 307 | |
(+) Cash & Short Term Investments | 0 | 112 | 33 | 28 | 43 | 37 | |
(+) Investments & Other | 0 | 16 | 0 | 0 | 0 | 39 | |
(-) Debt | (383) | (49) | (255) | (73) | (22) | (68) | |
(-) Other Liabilities | (46) | (1) | 0 | (0) | 0 | 0 | |
(-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 792 | 1,077 | 3,221 | 46 | 210 | 315 | |
(/) Shares Outstanding | 3.6 | 62.6 | 19.9 | 5.3 | 37.4 | 29.3 | |
Implied Stock Price | 223.00 | 17.22 | 161.50 | 8.62 | 5.62 | 10.76 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.07 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 223.00 | 17.22 | 150.60 | 8.62 | 5.62 | 10.76 | |
Trading Currency | EUR | EUR | CHF | EUR | EUR | EUR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.07 | 1.00 | 1.00 | 1.00 |